Keller, Arielle S. http://orcid.org/0000-0003-4708-1672
Pines, Adam R.
Shanmugan, Sheila
Sydnor, Valerie J. http://orcid.org/0000-0002-8640-668X
Cui, Zaixu http://orcid.org/0000-0003-4385-8106
Bertolero, Maxwell A. http://orcid.org/0000-0002-2691-3698
Barzilay, Ran
Alexander-Bloch, Aaron F. http://orcid.org/0000-0001-6554-1893
Byington, Nora
Chen, Andrew http://orcid.org/0000-0002-5027-6422
Conan, Gregory M.
Davatzikos, Christos http://orcid.org/0000-0002-1025-8561
Feczko, Eric
Hendrickson, Timothy J. http://orcid.org/0000-0001-6862-6526
Houghton, Audrey http://orcid.org/0000-0001-9426-7969
Larsen, Bart
Li, Hongming
Miranda-Dominguez, Oscar http://orcid.org/0000-0002-3622-0166
Roalf, David R. http://orcid.org/0000-0002-1728-9782
Perrone, Anders
Shetty, Alisha
Shinohara, Russell T.
Fan, Yong
Fair, Damien A. http://orcid.org/0000-0001-8602-393X
Satterthwaite, Theodore D. http://orcid.org/0000-0001-7072-9399
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01MH120482, R01EB022573, R37MH125829, R01MH113550)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 2 November 2022
Accepted: 29 November 2023
First Online: 18 December 2023
Competing interests
: R.B. reports owning stock in Taliaz Health and serving on the scientific boards of Taliaz Health and Zynerba Pharmaceuticals outside the submitted work. Dr. Shinohara has consulting income from Genentech/Roche and Octave Bioscience. All other authors report no competing interests.